[1]
Frederick M, Newman J, Kohlwes J. Leriche syndrome. Journal of general internal medicine. 2010 Oct:25(10):1102-4. doi: 10.1007/s11606-010-1412-z. Epub 2010 Jun 22
[PubMed PMID: 20568019]
[2]
Qi Y, Yang L, Zhang H, Liang E, Song L, Cai J, Jiang X, Zou Y, Qian H, Wu H, Zhou X, Hui R, Zheng D. The presentation and management of hypertension in a large cohort of Takayasu arteritis. Clinical rheumatology. 2018 Oct:37(10):2781-2788. doi: 10.1007/s10067-017-3947-4. Epub 2017 Dec 14
[PubMed PMID: 29238882]
Level 2 (mid-level) evidence
[3]
Chacko S, Joseph G, Thomson V, George P, George O, Danda D. Carbon dioxide Angiography-Guided Renal-Related Interventions in Patients with Takayasu Arteritis and Renal Insufficiency. Cardiovascular and interventional radiology. 2018 Jul:41(7):998-1007. doi: 10.1007/s00270-018-1936-x. Epub 2018 Mar 16
[PubMed PMID: 29549415]
[4]
Berger JS, Hochman J, Lobach I, Adelman MA, Riles TS, Rockman CB. Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories. Journal of vascular surgery. 2013 Sep:58(3):673-81.e1. doi: 10.1016/j.jvs.2013.01.053. Epub 2013 May 2
[PubMed PMID: 23642926]
[5]
Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, Pittrow D, von Stritzky B, Tepohl G, Trampisch HJ. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004 Jan:172(1):95-105
[PubMed PMID: 14709362]
Level 2 (mid-level) evidence
[6]
Criqui MH, Vargas V, Denenberg JO, Ho E, Allison M, Langer RD, Gamst A, Bundens WP, Fronek A. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation. 2005 Oct 25:112(17):2703-7
[PubMed PMID: 16246968]
[7]
Allison MA, Cushman M, Solomon C, Aboyans V, McDermott MM, Goff DC Jr, Criqui MH. Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis. Journal of vascular surgery. 2009 Nov:50(5):1049-56. doi: 10.1016/j.jvs.2009.05.061. Epub 2009 Jul 22
[PubMed PMID: 19628357]
[8]
Hackler EL 3rd, Hamburg NM, White Solaru KT. Racial and Ethnic Disparities in Peripheral Artery Disease. Circulation research. 2021 Jun 11:128(12):1913-1926. doi: 10.1161/CIRCRESAHA.121.318243. Epub 2021 Jun 10
[PubMed PMID: 34110901]
[9]
Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003 Sep 23:108(12):1527-32
[PubMed PMID: 14504252]
[11]
Wooten C, Hayat M, du Plessis M, Cesmebasi A, Koesterer M, Daly KP, Matusz P, Tubbs RS, Loukas M. Anatomical significance in aortoiliac occlusive disease. Clinical anatomy (New York, N.Y.). 2014 Nov:27(8):1264-74. doi: 10.1002/ca.22444. Epub 2014 Jul 25
[PubMed PMID: 25065617]
[12]
Narula N, Dannenberg AJ, Olin JW, Bhatt DL, Johnson KW, Nadkarni G, Min J, Torii S, Poojary P, Anand SS, Bax JJ, Yusuf S, Virmani R, Narula J. Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia. Journal of the American College of Cardiology. 2018 Oct 30:72(18):2152-2163. doi: 10.1016/j.jacc.2018.08.002. Epub 2018 Aug 27
[PubMed PMID: 30166084]
[13]
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, GVG Writing Group. Global vascular guidelines on the management of chronic limb-threatening ischemia. Journal of vascular surgery. 2019 Jun:69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28
[PubMed PMID: 31159978]
[14]
Society for Vascular Surgery Lower Extremity Guidelines Writing Group, Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, Moneta GL, Murad MH, Powell RJ, Reed AB, Schanzer A, Sidawy AN, Society for Vascular Surgery. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. Journal of vascular surgery. 2015 Mar:61(3 Suppl):2S-41S. doi: 10.1016/j.jvs.2014.12.009. Epub 2015 Jan 28
[PubMed PMID: 25638515]
Level 1 (high-level) evidence
[15]
Writing Committee Members, Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME, ACC/AHA Task Force Members, Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Pressler SJ, Wijeysundera DN. 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary. Vascular medicine (London, England). 2017 Jun:22(3):NP1-NP43. doi: 10.1177/1358863X17701592. Epub
[PubMed PMID: 28494710]
[16]
Guirguis-Blake JM, Evans CV, Redmond N, Lin JS. Screening for Peripheral Artery Disease Using the Ankle-Brachial Index: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018 Jul 10:320(2):184-196. doi: 10.1001/jama.2018.4250. Epub
[PubMed PMID: 29998343]
Level 1 (high-level) evidence
[17]
de Groote P, Millaire A, Deklunder G, Marache P, Decoulx E, Ducloux G. Comparative diagnostic value of ankle-to-brachial index and transcutaneous oxygen tension at rest and after exercise in patients with intermittent claudication. Angiology. 1995 Feb:46(2):115-22
[PubMed PMID: 7702195]
Level 2 (mid-level) evidence
[18]
Koelemay MJ, den Hartog D, Prins MH, Kromhout JG, Legemate DA, Jacobs MJ. Diagnosis of arterial disease of the lower extremities with duplex ultrasonography. The British journal of surgery. 1996 Mar:83(3):404-9
[PubMed PMID: 8665208]
[19]
Ahmed S, Raman SP, Fishman EK. CT angiography and 3D imaging in aortoiliac occlusive disease: collateral pathways in Leriche syndrome. Abdominal radiology (New York). 2017 Sep:42(9):2346-2357. doi: 10.1007/s00261-017-1137-0. Epub
[PubMed PMID: 28401281]
[20]
Romano M, Mainenti PP, Imbriaco M, Amato B, Markabaoui K, Tamburrini O, Salvatore M. Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease: diagnostic accuracy and interobserver agreement. European journal of radiology. 2004 Jun:50(3):303-8
[PubMed PMID: 15145492]
[21]
Menke J, Larsen J. Meta-analysis: Accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Annals of internal medicine. 2010 Sep 7:153(5):325-34. doi: 10.7326/0003-4819-153-5-201009070-00007. Epub
[PubMed PMID: 20820041]
Level 1 (high-level) evidence
[22]
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 Mar 21:135(12):e726-e779. doi: 10.1161/CIR.0000000000000471. Epub 2016 Nov 13
[PubMed PMID: 27840333]
Level 1 (high-level) evidence
[23]
Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, Lee IM, Lichtenstein AH, Loria CM, Millen BE, Nonas CA, Sacks FM, Smith SC Jr, Svetkey LP, Wadden TA, Yanovski SZ, Kendall KA, Morgan LC, Trisolini MG, Velasco G, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24:129(25 Suppl 2):S76-99. doi: 10.1161/01.cir.0000437740.48606.d1. Epub 2013 Nov 12
[PubMed PMID: 24222015]
Level 1 (high-level) evidence
[24]
Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, Strandness DE Jr, Taylor LM. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996 Dec 1:94(11):3026-49
[PubMed PMID: 8941154]
[25]
Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995 Sep 27:274(12):975-80
[PubMed PMID: 7674529]
Level 1 (high-level) evidence
[26]
Bouwens E, Klaphake S, Weststrate KJ, Teijink JA, Verhagen HJ, Hoeks SE, Rouwet EV. Supervised exercise therapy and revascularization: Single-center experience of intermittent claudication management. Vascular medicine (London, England). 2019 Jun:24(3):208-215. doi: 10.1177/1358863X18821175. Epub 2019 Feb 22
[PubMed PMID: 30795714]
[27]
Tara S, Kurobe H, de Dios Ruiz Rosado J, Best CA, Shoji T, Mahler N, Yi T, Lee YU, Sugiura T, Hibino N, Partida-Sanchez S, Breuer CK, Shinoka T. Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model. Arteriosclerosis, thrombosis, and vascular biology. 2015 Sep:35(9):2003-10. doi: 10.1161/ATVBAHA.115.306027. Epub 2015 Jul 16
[PubMed PMID: 26183618]
[28]
Bonaca MP, Creager MA, Olin J, Scirica BM, Gilchrist IC Jr, Murphy SA, Goodrich EL, Braunwald E, Morrow DA. Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 Trial. JACC. Cardiovascular interventions. 2016 Oct 24:9(20):2157-2164. doi: 10.1016/j.jcin.2016.07.034. Epub
[PubMed PMID: 27765312]
[29]
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA, TRA 2P–TIMI 50 Steering Committee and Investigators. Vorapaxar in the secondary prevention of atherothrombotic events. The New England journal of medicine. 2012 Apr 12:366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24
[PubMed PMID: 22443427]
[30]
WAVE Investigators. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials. American heart journal. 2006 Jan:151(1):1-9
[PubMed PMID: 16368284]
Level 1 (high-level) evidence
[31]
Warfarin Antiplatelet Vascular Evaluation Trial Investigators, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. The New England journal of medicine. 2007 Jul 19:357(3):217-27
[PubMed PMID: 17634457]
[32]
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S, COMPASS Investigators. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. The New England journal of medicine. 2017 Oct 5:377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27
[PubMed PMID: 28844192]
[33]
Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S, COMPASS Investigators. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2018 Jan 20:391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10
[PubMed PMID: 29132880]
Level 1 (high-level) evidence
[34]
Metcalfe MJ, Natarajan R, Selvakumar S. Use of extraperitoneal iliac artery endarterectomy in the endovascular era. Vascular. 2008 Nov-Dec:16(6):310-5
[PubMed PMID: 19344587]
[35]
Krankenberg H, Schlüter M, Schwencke C, Walter D, Pascotto A, Sandstede J, Tübler T. Endovascular reconstruction of the aortic bifurcation in patients with Leriche syndrome. Clinical research in cardiology : official journal of the German Cardiac Society. 2009 Oct:98(10):657-64. doi: 10.1007/s00392-009-0052-y. Epub 2009 Aug 14
[PubMed PMID: 19685001]
[36]
Rutherford RB. Options in the surgical management of aorto-iliac occlusive disease: a changing perspective. Cardiovascular surgery (London, England). 1999 Jan:7(1):5-12
[PubMed PMID: 10073753]
Level 3 (low-level) evidence
[37]
Kang N, Kenel-Pierre S, DeAmorim H, Karwowski J, Bornak A. Endovascular Aortoiliac Revascularization in a Patient with Spinal Cord Injury and Hip Contracture. Annals of vascular surgery. 2018 Feb:47():281.e1-281.e4. doi: 10.1016/j.avsg.2017.08.039. Epub 2017 Sep 8
[PubMed PMID: 28893707]
[38]
Shah SS, Pillai GS, Greif BA, Wang S, Lewis AJ, Ryer EJ, Elmore JR, Salzler GG. Outcomes of Aortobifemoral Bypass Based on Configuration of the Proximal Anastomosis. Annals of vascular surgery. 2023 Nov:97():66-73. doi: 10.1016/j.avsg.2023.05.007. Epub 2023 May 25
[PubMed PMID: 37244482]
[39]
Pursell R, Sideso E, Magee TR, Galland RB. Critical appraisal of femorofemoral crossover grafts. The British journal of surgery. 2005 May:92(5):565-9
[PubMed PMID: 15810055]
[40]
Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II. Journal of vascular surgery. 2011 Apr:53(4):992-9. doi: 10.1016/j.jvs.2010.10.069. Epub 2011 Jan 7
[PubMed PMID: 21215582]
Level 3 (low-level) evidence
[41]
Van Haren RM, Goldstein LJ, Velazquez OC, Karmacharya J, Bornak A. Endovascular treatment of TransAtlantic Inter-Society Consensus D aortoiliac occlusive disease using unibody bifurcated endografts. Journal of vascular surgery. 2017 Feb:65(2):398-405. doi: 10.1016/j.jvs.2016.08.084. Epub 2016 Oct 17
[PubMed PMID: 27765483]
Level 3 (low-level) evidence
[42]
Groot Jebbink E, Holewijn S, Slump CH, Lardenoije JW, Reijnen MMPJ. Systematic Review of Results of Kissing Stents in the Treatment of Aortoiliac Occlusive Disease. Annals of vascular surgery. 2017 Jul:42():328-336. doi: 10.1016/j.avsg.2017.01.009. Epub 2017 Apr 6
[PubMed PMID: 28390920]
Level 1 (high-level) evidence
[43]
Mwipatayi BP, Thomas S, Wong J, Temple SE, Vijayan V, Jackson M, Burrows SA, Covered Versus Balloon Expandable Stent Trial (COBEST) Co-investigators. A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease. Journal of vascular surgery. 2011 Dec:54(6):1561-70. doi: 10.1016/j.jvs.2011.06.097. Epub 2011 Sep 9
[PubMed PMID: 21906903]
[44]
Piffaretti G, Fargion AT, Dorigo W, Pulli R, Gattuso A, Bush RL, Pratesi C, ILIACS Registry Group. Outcomes From the Multicenter Italian Registry on Primary Endovascular Treatment of Aortoiliac Occlusive Disease. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2019 Oct:26(5):623-632. doi: 10.1177/1526602819863081. Epub 2019 Jul 22
[PubMed PMID: 31331235]
[45]
Morotti A, Busso M, Cinardo P, Bonomo K, Angelino V, Cardinale L, Veltri A, Guerrasio A. When collateral vessels matter: asymptomatic Leriche syndrome. Clinical case reports. 2015 Nov:3(11):960-1. doi: 10.1002/ccr3.390. Epub 2015 Sep 10
[PubMed PMID: 26576282]
Level 3 (low-level) evidence
[46]
Aboyans V, Desormais I, Lacroix P, Salazar J, Criqui MH, Laskar M. The general prognosis of patients with peripheral arterial disease differs according to the disease localization. Journal of the American College of Cardiology. 2010 Mar 2:55(9):898-903. doi: 10.1016/j.jacc.2009.09.055. Epub
[PubMed PMID: 20185041]
[47]
Lee GC, Yang SS, Park KM, Park Y, Kim YW, Park KB, Park HS, Do YS, Kim DI. Ten year outcomes after bypass surgery in aortoiliac occlusive disease. Journal of the Korean Surgical Society. 2012 Jun:82(6):365-9. doi: 10.4174/jkss.2012.82.6.365. Epub 2012 May 29
[PubMed PMID: 22708098]
[48]
Indes JE, Pfaff MJ, Farrokhyar F, Brown H, Hashim P, Cheung K, Sosa JA. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2013 Aug:20(4):443-55. doi: 10.1583/13-4242.1. Epub
[PubMed PMID: 23914850]
Level 2 (mid-level) evidence
[49]
Keller K, Beule J, Oliver Balzer J, Coldewey M, Munzel T, Dippold W, Wild P. A 56-year-old man with co-prevalence of Leriche syndrome and dilated cardiomyopathy: case report and review. Wiener klinische Wochenschrift. 2014 Mar:126(5-6):163-8. doi: 10.1007/s00508-013-0476-2. Epub 2013 Dec 17
[PubMed PMID: 24343041]
Level 3 (low-level) evidence
[50]
Kashou AH, Braiteh N, Zgheib A, Kashou HE. Acute aortoiliac occlusive disease during percutaneous transluminal angioplasty in the setting of ST-elevation myocardial infarction: a case report. Journal of medical case reports. 2018 Jan 11:12(1):6. doi: 10.1186/s13256-017-1544-4. Epub 2018 Jan 11
[PubMed PMID: 29321037]
Level 3 (low-level) evidence
[51]
JOHNSON JK. Ascending thrombosis of abdominal aorta as fatal complication of Leriche's syndrome. A.M.A. archives of surgery. 1954 Nov:69(5):663-8
[PubMed PMID: 13206556]
[52]
Bredahl K, Jensen LP, Schroeder TV, Sillesen H, Nielsen H, Eiberg JP. Mortality and complications after aortic bifurcated bypass procedures for chronic aortoiliac occlusive disease. Journal of vascular surgery. 2015 Jul:62(1):75-82. doi: 10.1016/j.jvs.2015.02.025. Epub
[PubMed PMID: 26115920]